Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) EBITDA (2016 - 2025)

Historic EBITDA for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $72.0 million.

  • Pediatrix Medical's EBITDA rose 23992.73% to $72.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.8 million, marking a year-over-year increase of 16499.87%. This contributed to the annual value of -$97.9 million for FY2024, which is 6629.48% down from last year.
  • According to the latest figures from Q3 2025, Pediatrix Medical's EBITDA is $72.0 million, which was up 23992.73% from $39.7 million recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's EBITDA peaked at $72.0 million during Q3 2025, and registered a low of -$152.8 million during Q2 2024.
  • Over the past 5 years, Pediatrix Medical's median EBITDA value was $26.1 million (recorded in 2021), while the average stood at $12.7 million.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 64785.8% in 2024, then surged by 42542.12% in 2025.
  • Pediatrix Medical's EBITDA (Quarter) stood at $68.0 million in 2021, then tumbled by 55.85% to $30.0 million in 2022, then tumbled by 509.61% to -$123.0 million in 2023, then skyrocketed by 124.08% to $29.6 million in 2024, then soared by 143.15% to $72.0 million in 2025.
  • Its last three reported values are $72.0 million in Q3 2025, $39.7 million for Q2 2025, and $21.5 million during Q1 2025.